Mydriatic microdrops during retinopathy of prematurity (ROP) screening were noninferior to standard drops, which have been associated with cardiorespiratory and gastrointestinal adverse events, a ...

Please provide your email address to receive an email when new articles are posted on . Despite developments such as the FDA approval of Eylea, disparities are still present in access to care for ...

Please provide your email address to receive an email when new articles are posted on . A study published in 2023 that analyzed more than 23 million births found that the proportion of premature ...

Retinopathy of Prematurity (ROP) is the leading cause of preventable childhood blindness globally. As medical advances allow more premature and extremely premature infants to survive, the number of ...